The DOI matches its Crossref record; 264 of the 273 references it cites were found in a registry or an index.
Implications of genetic variation in the complement system in age-related macular degeneration
Open accessAbstract
Age-related macular degeneration (AMD) is the main cause of vision loss among the elderly in the Western world. While AMD is a multifactorial disease, the complement system was identified as one of the main pathways contributing to disease risk. The strong link between the complement system and AMD was demonstrated by genetic associations, and by elevated complement activation in local eye tissue and in the systemic circulation of AMD patients. Several complement inhibitors have been and are being explored in clinical trials, but thus far with limited success, leaving the majority of AMD patients without treatment options to date. This indicates that there is still a gap of knowledge regarding the functional implications of the complement system in AMD pathogenesis and how to bring these towards clinical translation. Many different experimental set-ups and disease models have been used to study complement activation in vivo and in vitro, and recently emerging patient-derived induced pluripotent stem cells and genome-editing techniques open new opportunities to study AMD disease mechanisms and test new therapeutic strategies in the future. In this review we provide an extensive overview of methods employed to understand the molecular processes of complement activation in AMD pathogenesis. We discuss the findings, advantages and challenges of each approach and conclude with an outlook on how recent, exciting developments can fill in current knowledge gaps and can aid in the development of effective complement-targeting therapeutic strategies in AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Müller cells are also considered a major source of complement proteins in the inner retina [115,130,277].”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [277]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Gong, J., Cai, H., NYSCF Global Stem Cell Array Team, Noggle, S., Paull, D. J., Rizzolo, L. J., Priore, L. V. D., & Fields, M. A. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0321 · Cited by 50
Novel Role for a Complement Regulatory Protein (CD46) in Retinal Pigment Epithelial Adhesion
McLaughlin, B. J., Fan, W., Zheng, J. J., Cai, H., Priore, L. V. D., Bora, N. S., & Kaplan, H. J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0813 · Cited by 48
Matrix metalloproteases as a pharmacological target in cardiovascular diseases.
Hopps, E., & Caimi, G. (2015) · PubMed · Cited by 48
Smith, E. N., D’Antonio‐Chronowska, A., Greenwald, W. W. Y., Borja, V., Aguiar, L. R., Pogue, R. E., Matsui, H., Benaglio, P., Borooah, S., D’Antonio, M., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.012 · Cited by 48
C9-R95X Polymorphism in Patients with Neovascular Age-Related Macular Degeneration
Nishiguchi, K. M., Yasuma, T. R., Tomida, D., Nakamura, M., Ishikawa, K., Kikuchi, M., Ohmi, Y., Niwa, T., Hamajima, N., Furukawa, K., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8425 · Cited by 47
Silva, A. S., Teixeira, A., Bavia, L., Lin, F. L. H., Velletri, R., Belfort, R., & Isaac, L. (2012) · Europe PMC (PubMed Central) · Cited by 46
Calaza, K. D. C., Kam, J. H., Hogg, C. R., & Jeffery, G. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.010 · Cited by 45
Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular Degeneration
Songstad, A. E., Wiley, L. A., Duong, K., Kaalberg, E. E., Flamme‐Wiese, M. J., Cranston, C. M., Riker, M. J., Levasseur, D. N., Stone, E. M., Mullins, R. F., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17073 · Cited by 45
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
The Application of Biomaterials to Tissue Engineering Neural Retina and Retinal Pigment Epithelium
Hunt, N. C., Hallam, D., Chichagova, V., STEEL, D. H., & Lako, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800226 · Cited by 45
Trakkides, T.-O., Schäfer, N., Reichenthaler, M., Kühn, K., Brandwijk, R. J. M. G. E., Toonen, E. J. M., Urban, F., Wegener, J., Enzmann, V., & Pauly, D. (2019) · Antioxidants · doi:10.3390/antiox8110548 · Cited by 45
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 42
Seddon, J. M., Widjajahakim, R., & ROSNER, B. A. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.32 · Cited by 42
Complement Regulatory Protein CD46 Protects against Choroidal Neovascularization in Mice
Lyzogubov, V., Wu, X., Jha, P., Tytarenko, R., Triebwasser, M., Kolar, G., Bertram, P., Bora, P. S., Atkinson, J. P., & Bora, N. S. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.06.001 · Cited by 41
Emri, E., Körtvely, E., Dammeier, S., Klose, F., Simpson, D. A. C., den Hollander, A. I., Ueffing, M., & Lengyel, I. (2020) · Nutrients · doi:10.3390/nu12103051 · Cited by 41
Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding
Volokhina, E. B., Westra, D., Xue, X., Gros, P., van de Kar, N. C. A. J., & van den Heuvel, L. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2183-z · Cited by 40
Self-citationSongstad, A. E., Worthington, K. S., Chirco, K. R., Giacalone, J. C., Whitmore, S. S., Anfinson, K. R., Ochoa, D., Cranston, C. M., Riker, M. J., Neiman, M., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0399 · Cited by 40
Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
Busch, C., Annamalai, B., Abdusalamova, K., Reichhart, N., Huber, C., Lin, Y., Jo, E. A. H., Zipfel, P. F., Skerka, C., Wildner, G., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00703 · Cited by 40
Analysis of Rare Variants in the C3 Gene in Patients with Age-Related Macular Degeneration
Duvvari, M. R., Paun, C. C., Buitendijk, G. H. S., Saksens, N. T. M., Volokhina, E. B., Ristau, T., Schoenmaker-Koller, F. E., van de Ven, J. P. H., Groenewoud, J. M. M., van den Heuvel, L. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094165 · Cited by 39
Self-citationJava, A., Baciu, P. C., Widjajahakim, R., Sung, Y. J., Yang, J., Kavanagh, D., Atkinson, J. P., & Seddon, J. M. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.9.37 · Cited by 39
Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Scholl, H. P. N., Charbel Issa, P., Walier, M., Janzer, S., Pollok-Kopp, B., Börncke, F., Fritsche, L. G., Chong, N. V., Fimmers, R., Wienker, T., et al. (2008) · PLoS ONE · doi:10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad · Cited by 39
Paun, C. C., Lechanteur, Y. T. E., Groenewoud, J. M. M., Altay, L., Schick, T., Daha, M. R., Fauser, S., Hoyng, C. B., den Hollander, A. I., & de Jong, E. K. (2016) · Scientific Reports · doi:10.1038/srep26568 · Cited by 37
Self-citationSzarvas, N., Szilágyi, Á., Csuka, D., Takács, B., Rusai, K., Müller, T. R., Arbeiter, K., Réti, M., Haris, A., Wagner, L. J., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.01.003 · Cited by 36
Baek, J., Lim, D., Park, K. H., Chae, J., Jang, H., Lee, J., & Chung, H. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0941-9 · Cited by 36
Sivapathasuntharam, C., Hayes, M. J., Shinhmar, H., Kam, J. H., Sivaprasad, S., & Jeffery, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-37673-6 · Cited by 35
C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial Cells
Long, Q., Cao, X., Bian, A., & Li, Y. (2016) · BioMed Research International · doi:10.1155/2016/6958752 · Cited by 34
Altay, L., Sitnilska, V., Schick, T., Widmer, G., Duchâteau-Nguyen, G., Piraino, P., Jayagopal, A., Drawnel, F., & Fauser, S. (2019) · Eye · doi:10.1038/s41433-019-0501-4 · Cited by 34
Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases
Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., Coco, R., Pinto, S., Noris, M., García-Layana, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050580 · Cited by 32
Analysis of Binding Sites on Complement Factor I That Are Required for Its Activity
Nilsson, S. C., Nita, I., Månsson, L., Groeneveld, T. W. L., Trouw, L. A., Villoutreix, B. O., & Blom, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097212 · Cited by 32
Ren, X., Li, J., Xu, X., Wang, C., & Cheng, Y. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.02.004 · Cited by 31
Lashkari, K., Teague, G. C., Chen, H., Lin, Y.-Q., Kumar, S., McLaughlin, M., & López, F. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195751 · Cited by 31
Animal models of age-related macular degeneration and their translatability into the clinic
Chen, S., Popp, N. A., & Chan, C. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.939171 · Cited by 30
Fields, M. A., Bowrey, H. E., Gong, J., Moreira, E. F., Cai, H., & Priore, L. V. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177763 · Cited by 29
Molecular characterization of complement Factor I deficiency in two Spanish families
Castro, I. M. P., González-Rubio, C., Delgado-Cerviño, E. M., Abarrategui-Garrido, C., Fontán, G., Sánchez‐Corral, P., & López‐Trascasa, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.02.008 · Cited by 28
Wang, J. C. C., Cao, S., Wang, A., To, E. C., Law, G., Gao, J., Zhang, D., Cui, J. Z., & Matsubara, J. A. (2015) · Europe PMC (PubMed Central) · Cited by 25
Luo, M., & Chen, Y. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.23 · Cited by 25
Schäfer, N., Wolf, H. N., Enzbrenner, A., Schikora, J., Reichenthaler, M., Enzmann, V., & Pauly, D. (2020) · Antioxidants · doi:10.3390/antiox9090793 · Cited by 24
Mannes, M., Dopler, A., Huber-Lang, M. S., & Schmidt, C. Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596415 · Cited by 23
Fanelli, G., Gonzalez-Cordero, A., Gardner, P. J., Peng, Q., Fernando, M., Kloc, M., Farrar, C. A., Naeem, A., Garred, P., Ali, R. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15212-z · Cited by 22
A model to study complement involvement in experimental retinal degeneration
Mohlin, C., Sandholm, K., Kvanta, A., Ekdahl, K. N., & Johansson, K. U. I. (2018) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2018.1431744 · Cited by 22
Geerlings, M. J., Volokhina, E. B., de Jong, E. K., van de Kar, N. C. A. J., Pauper, M., Hoyng, C. B., van den Heuvel, L. P., & den Hollander, A. I. (2018) · Clinical Genetics · doi:10.1111/cge.13392 · Cited by 21
Self-citationZhang, Y., Huang, Q. B., Tang, M., Zhang, J., & Fan, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129945 · Cited by 20
Tan, P. L., Garrett, M. E., Willer, J. R., Campochiaro, P. A., Campochiaro, B., Zack, D. J., Ashley‐Koch, A. E., & Katsanis, N. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20867 · Cited by 20
Toomey, C. B., Landowski, M., Klingeborn, M., Kelly, U., Deans, J. R., Dong, H., Harrabi, O., Blarcom, T. J. V., Yeung, Y. A., Grishanin, R. N., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23134 · Cited by 20
Kremlitzka, M., Geerlings, M. J., de Jong, S., Bakker, B., Nilsson, S. C., Fauser, S., Hoyng, C. B., de Jong, E. K., den Hollander, A. I., & Blom, A. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy178 · Cited by 20
Java, A., Pozzi, N., Love-Gregory, L. D., Heusel, J. W., Sung, Y. J., Hu, H., Bertram, P. G., Liszewski, M. K., Cline, L. M., Ren, Z., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.04.003 · Cited by 20
GT005, a gene therapy for the treatment of dry age-related macular degeneration (AMD)
Ellis, S., Buchberger, A. M. S., Holder, J. C., Orhan, E., & Hughes, J. (2020) · Investigative Ophthalmology & Visual Science · Cited by 20
van Doorn, K. J., Dirinck, E. L., Verpooten, G. A., & Couttenye, M. M. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sfs190 · Cited by 18
Predictive Model for Earlier Diagnosis of Suspected Age-Related Macular Degeneration Patients
Sharma, N. K., Sharma, S., Gupta, A., Prabhakar, S. K., Singh, R., & Anand, A. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2072 · Cited by 17
Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
Mohlin, F. C., Gros, P., Mercier, É., Gris, J., & Blom, A. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01813 · Cited by 17
Sugita, S., Makabe, K., Fujii, S., & Takahashi, M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24769 · Cited by 17
Guymer, R. H., Cipriani, T., Rittenhouse, K. D., Lim, L. L., Robman, L. D., Li, W., Wang, W., Deng, S., & Banerjee, P. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-015-2970-x · Cited by 16
Hughes, A. E., Bridgett, S., Meng, W., Li, M., Curcio, C. A., Stambolian, D., & Bradley, D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18744 · Cited by 16
Chu, P., Chen, G., Kuo, D. C., Braisted, J. C., Huang, R., Wang, Y., Simeonov, A. M., Boehm, M., & Gerhold, D. L. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00363 · Cited by 16
Mechanisms of FH Protection Against Neovascular AMD
Borras, C., Delaunay, K., Slaoui, Y., Abache, T., Jorieux, S., Naud, M., Sanharawi, M. E., Gélizé, E., Lassiaz, P., An, N., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00443 · Cited by 16
Complement C3 inhibitor POT-4: Clinical Safety of Intravitreal Administration
Kaushal, S., Grossi, F. V., Francois, C. G., & Slakter, J. S. (2009) · Investigative Ophthalmology & Visual Science · Cited by 13
Arya, S., Emri, E., Synowsky, S. A., Shirran, S. L., Barzegar-Befroei, N., Pető, T., Botting, C. H., Lengyel, I., & Stewart, A. J. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.03.023 · Cited by 11
Ablation of C3 modulates macrophage reactivity in the outer retina during photo-oxidative damage.
Jiao, H., Provis, J. M., Natoli, R., & Rutar, M. (2020) · PubMed Central · Cited by 11
Weinberger, A. W. A., Eddahabi, C., Carstesen, D., Zipfel, P. F., Walter, P., & Skerka, C. (2013) · Ophthalmic Research · doi:10.1159/000351624 · Cited by 10
Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B
Pilotti, C., Greenwood, J., & Moss, S. E. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.5.19 · Cited by 10
NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future
Wright, C. B., Mazzucco, A. E., Becker, S. M., Sieving, P. A., & Tumminia, S. J. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.7.49 · Cited by 8
Clare, A. J., Copland, D. A., Nicholson, L. B., Liu, J., Neal, C., Moss, S. E., Dick, A. D., & Theodoropoulou, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16000 · Cited by 7
Adaptive and Maladaptive Complement Activation in the Retina
Silverman, S. M., & Wong, W. T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-27378-1_6 · Cited by 3
Chang, M., Steffen, V., Honigberg, L. A., & Edmonds, R. (2020) · Investigative Ophthalmology & Visual Science · Cited by 1
Research works printed but not linked: 3
- Cipriani, 2020, Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration, Nat. Commun., 11, 778, 10.1038/s41467-020-14499-3 · DOI
- Gallemore, 2016, A proof of concept study of intravitreal (IVT) LFG316 in patients with neovascular age realted macular degeneration (nAMD), Invest. Ophthalmol. Vis. Sci., 57
- Weismann, 2011, Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, 478, 76, 10.1038/nature10449 · DOI · Paper page
Cited by
Sorted by citations
The role of the gut microbiome in eye diseases
Zysset‐Burri, D. C., Morandi, S. C., Herzog, E. L., Berger, L., & Zinkernagel, M. S. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101117 · Cited by 103
Bharti, K., den Hollander, A. I., Lakkaraju, A., Sinha, D., Williams, D. S., Finnemann, S. C., Rickman, C. B., Malek, G., & D'Amore, P. A. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109170 · Cited by 98
The retinal pigmentation pathway in human albinism: Not so black and white
Bakker, R., Wagstaff, E. L., Kruijt, C. C., Emri, E., van Karnebeek, C., Hoffmann, M. B., Brooks, B. P., Boon, C. J. F., Montoliu, L., van Genderen, M. M., et al. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101091 · Cited by 88
Inflammation and retinal degenerative diseases
Kaur, G., & Singh, N. K. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.350192 · Cited by 90
Fernandes, A. R., Zielińska, A., Sánchez‐López, E., dos Santos, T., García, M. L., Silva, A. M., Karczewski, J., & Souto, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052592 · Cited by 82
Metadata
- Authors
- de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I.
- Affiliations
- Radboud University Medical Center (NL)
- Radboud University Nijmegen (NL)
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 84
- Pages
- 100952
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W3131044740
- Cited by
- 71
- References
- 273
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 12 · 2023: 14 · 2022: 17 · 2021: 7
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Progress in Retinal and Eye Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Foundation Fighting Blindness Inc
- Dutch Research Council
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, complement system, complement activation, genetic variation, genetic association, complement inhibitors, AMD pathogenesis, induced pluripotent stem cells, genome editing, disease models
- MeSH terms
- Aged, Complement System Proteins, Complement Activation, Humans, Macular Degeneration, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review